Replies to post #89381 on Biotech Values

[mcbio]

Re: GHDX

GHDX is a stock that hasn't gotten much attention in these parts. If anyone here follows this name, please chime in.

I had never heard of the company until now. It looks like a pure-play diagnostic bet on personalized medicine. Pretty significant revenues for a small company (~$150M for FYE2009), good growth, and a few big partners (BMS, LLY, PFE). I'm inclined to dig a little deeper.

[mcbio]

Re: GHDX

GHDX is a stock that hasn't gotten much attention in these parts. If anyone here follows this name, please chime in.

Any thoughts on GHDX here? It's drifted from around $20 when last discussed on here to under $16 now. Although I normally don't get too excited about diagnostic plays as they're not all that 'sexy,' GHDX does seem a bit more interesting as it's a pure play on personalized medicine and I guess the bottom line is the bottom line.

Baker Brothers bought a few chunks back in February (not sure if you have any opinions on them). Any thoughts, though, on the high short ratio (over 20% at end of April)? GHDX is trading at under 3x sales and the company is projecting solid growth going forward, so I'm not sure what I'm missing to account for the large short interest.